CALIDI BIOTHERAPEUTICS, INC. - Common stock, par value $0.0001 per share (CLDI)

CUSIP: 320703309

Q3 2024 13F Holders as of 30 Sep 2024

Holder snapshot 6 signals
Share change
+161,945
SEC-reported price per share
$1.14
Number of holders
19
Value change
+$331,789
Number of buys
18
Number of sells
2
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
11,128,448

Security key

320703309

Report period

Q3 2024

Institutions

19

Top holders

10

Ownership snapshot

Top reported holders of CLDI - CALIDI BIOTHERAPEUTICS, INC. - Common stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
DRIEHAUS CAPITAL MANAGEME...
Disclosed value leader
Polar Asset Management Pa...
Comparable rows
2/15
Latest evidence
30 Jun 2024
13F 3/4/5 Lead comparable stake: 0.85% 13 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

DRIEHAUS CAPITAL MANAGEMENT LLC leads the comparable SEC ownership view at 0.85%.

2 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens DRIEHAUS CAPITAL MANAGEMENT LLC's linked filing trail.
Comparable ownership Top 2
DRIEHAUS CAPITAL MANAGEMENT LLC 0.85%
MARSHALL WACE, LLP 0.56%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
DRIEHAUS CAPITAL MANAGEMENT LLC
13F
Company
13F
0.85%
$18,939
94,697 shares
30 Jun 2024
MARSHALL WACE, LLP
13F
Company
13F
0.56%
$12,373
61,869 shares
30 Jun 2024
Polar Asset Management Partners Inc.
3/4/5 13F
10%+ Owner · Company
mixed-class rows
$4,330,272
412,800 shares
19 Oct 2022
First Light Acquisition Group, LLC
3/4/5
10%+ Owner
class O/S missing
1,931,852 shares
16 Jun 2023
Stephen Thesing
3/4/5
Chief Business Officer
class O/S missing
$848,779
471,544 shares
12 Sep 2023
Boris Radoslavov Minev
3/4/5
Interim Chief Medical Officer
mixed-class rows
$764,024
455,818 shares
mixed-class rows
17 Jun 2024
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q3 2024

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
19
Shares
318,770
Rows available
19
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q3 2024 vs Q2 2024 Across Filers

Q2 2024 holders
2
Q3 2024 holders
19
Holder diff
17
Investor Q2 2024 Shares Q3 2024 Shares Share Diff Share Chg % Q2 2024 value Q3 2024 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .